Impact of atrial fibrillation catheter ablation on mortality, stroke, and heart failure hospitalizations: A meta‐analysis

The impact of atrial fibrillation catheter ablation (AFCA) on hard clinical endpoints remains controversial.

[1]  P. Noseworthy,et al.  Atrial fibrillation ablation in practice: assessing CABANA generalizability , 2019, European heart journal.

[2]  G. Hindricks,et al.  Effect of Catheter Ablation vs Antiarrhythmic Drug Therapy on Mortality, Stroke, Bleeding, and Cardiac Arrest Among Patients With Atrial Fibrillation: The CABANA Randomized Clinical Trial , 2019, JAMA.

[3]  A. Verma,et al.  Long‐term risk of stroke and bleeding post–atrial fibrillation ablation , 2018, Journal of cardiovascular electrophysiology.

[4]  É. Marijon,et al.  Association of catheter ablation for atrial fibrillation with mortality and stroke: A systematic review and meta-analysis. , 2018, International journal of cardiology.

[5]  G. Xing,et al.  California Study of Ablation for Atrial Fibrillation:Re-hospitalization for Cardiac Events (CAABL-CE). , 2018, Journal of atrial fibrillation.

[6]  E. Amsterdam,et al.  CAABL-AF (California Study of Ablation for Atrial Fibrillation): Mortality and Stroke, 2005 to 2013 , 2018, Circulation. Arrhythmia and electrophysiology.

[7]  E. Kaluski,et al.  The Clinical Benefits and Mortality Reduction Associated With Catheter Ablation in Subjects With Atrial Fibrillation: A Systematic Review and Meta-Analysis. , 2018, JACC. Clinical electrophysiology.

[8]  L. Jordaens,et al.  Catheter Ablation for Atrial Fibrillation with Heart Failure , 2018, The New England journal of medicine.

[9]  H. Calkins,et al.  Should We Perform Catheter Ablation for Asymptomatic Atrial Fibrillation? , 2017, Circulation.

[10]  N. Gronich,et al.  Catheter ablation of atrial fibrillation is associated with reduced risk of stroke and mortality: A propensity score-matched analysis. , 2017, Heart rhythm.

[11]  Dhanunjaya R. Lakkireddy,et al.  Ablation Versus Amiodarone for Treatment of Persistent Atrial Fibrillation in Patients With Congestive Heart Failure and an Implanted Device: Results From the AATAC Multicenter Randomized Trial , 2016, Circulation.

[12]  L. Friberg,et al.  Catheter ablation for atrial fibrillation is associated with lower incidence of stroke and death: data from Swedish health registries. , 2016, European heart journal.

[13]  L. Køber,et al.  Oral anticoagulation therapy after radiofrequency ablation of atrial fibrillation and the risk of thromboembolism and serious bleeding: long-term follow-up in nationwide cohort of Denmark. , 2015, European heart journal.

[14]  R. Hunter,et al.  Catheter Ablation of Atrial Fibrillation in Patients With Left Ventricular Systolic Dysfunction: A Systematic Review and Meta-Analysis , 2014, Circulation. Arrhythmia and electrophysiology.

[15]  M. Lai,et al.  Effect of Radiofrequency Catheter Ablation for Atrial Fibrillation on Morbidity and Mortality: A Nationwide Cohort Study and Propensity Score Analysis , 2014, Circulation. Arrhythmia and electrophysiology.

[16]  Jamil Mayet,et al.  A Randomized Controlled Trial of Catheter Ablation Versus Medical Treatment of Atrial Fibrillation in Heart Failure (The CAMTAF Trial) , 2014, Circulation. Arrhythmia and electrophysiology.

[17]  Lluís Mont,et al.  Catheter ablation vs. antiarrhythmic drug treatment of persistent atrial fibrillation: a multicentre, randomized, controlled trial (SARA study) , 2013, European heart journal.

[18]  Tom Wong,et al.  A randomized trial to assess catheter ablation versus rate control in the management of persistent atrial fibrillation in heart failure. , 2013, Journal of the American College of Cardiology.

[19]  J. Hartikainen,et al.  Radiofrequency ablation as initial therapy in paroxysmal atrial fibrillation. , 2012, The New England journal of medicine.

[20]  M. Reynolds,et al.  Health Outcomes With Catheter Ablation or Antiarrhythmic Drug Therapy in Atrial Fibrillation: Results of a Propensity-Matched Analysis , 2012, Circulation. Cardiovascular quality and outcomes.

[21]  R. Hunter,et al.  Maintenance of sinus rhythm with an ablation strategy in patients with atrial fibrillation is associated with a lower risk of stroke and death , 2011, Heart.

[22]  B. Horne,et al.  Patients Treated with Catheter Ablation for Atrial Fibrillation Have Long‐Term Rates of Death, Stroke, and Dementia Similar to Patients Without Atrial Fibrillation , 2011, Journal of cardiovascular electrophysiology.

[23]  Michele Tarsilla.  Cochrane Handbook for Systematic Reviews of Interventions , 2010, Journal of MultiDisciplinary Evaluation.

[24]  Burr Hall,et al.  Comparison of antiarrhythmic drug therapy and radiofrequency catheter ablation in patients with paroxysmal atrial fibrillation: a randomized controlled trial. , 2010, JAMA.

[25]  J. Ioannidis,et al.  The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration , 2009, Annals of Internal Medicine [serial online].

[26]  F. Sacher,et al.  Catheter Ablation Versus Antiarrhythmic Drugs for Atrial Fibrillation: The A4 Study , 2008, Circulation.

[27]  Antonio De Simone,et al.  Catheter ablation treatment in patients with drug-refractory atrial fibrillation: a prospective, multi-centre, randomized, controlled study (Catheter Ablation For The Cure Of Atrial Fibrillation Study). , 2006, European heart journal.

[28]  Mandeep Bhargava,et al.  Radiofrequency ablation vs antiarrhythmic drugs as first-line treatment of symptomatic atrial fibrillation: a randomized trial. , 2005, JAMA.

[29]  H. Crijns,et al.  A comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillation , 2002 .

[30]  A L Waldo,et al.  A comparison of rate control and rhythm control in patients with atrial fibrillation. , 2002, The New England journal of medicine.